In addition to nutritional supplements, the partnership will focus on developing medical information and “supportive services” for healthcare professionals and their patients.
Pharmaceutical group Helsinn Group (Lugano, Switzerland) has made a minority investment in Thorne Research Inc., a manufacturer of nutritional supplements marketed through healthcare practitioners. The companies will develop dietary supplements to support the unique needs of cancer patients.
“We believe there is a clear need for high-quality, clinically specific nutrition products for conditions related to cancer,” stated Riccardo Braglia, CEO of Helsinn Group.
In addition to nutritional supplements, the partnership will focus on developing medical information and “supportive services” for healthcare professionals and their patients.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.